| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $145.0M | +39.1% |
| SG&A Expense | $27.2M | +200.1% |
| Operating Income | -$172.2M | -52.0% |
| Interest Expense | $14.4M | +39.8% |
| Pre-tax Income | -$177.0M | -58.4% |
| Net Income | -$177.0M | -58.4% |
| EPS (Basic) | -$3.79 | -33.9% |
| EPS (Diluted) | -$3.79 | -33.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $165.7M | +636.0% |
| Short-term Investments | $275.8M | +29.7% |
| Current Assets | $465.7M | +90.4% |
| Total Assets | $466.6M | +90.3% |
| Current Liabilities | $44.2M | +39.2% |
| Long-term Debt | $137.5M | +30.9% |
| Total Liabilities | $366.0M | +182.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$153.3M | -83.6% |
| Capital Expenditures | $249K | -0.4% |
| Investing Cash Flow | -$64.1M | -1.6% |
| Financing Cash Flow | $360.6M | +160.5% |
| Free Cash Flow | -$153.5M | -83.4% |
| $100.6M |
| -13.0% |